LeonaBio, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -13.2% | -16.7% | -16.6% | -22.5% | -31.8% | -26.0% | -18.3% | -15.5% | +206.8% | -22.3% | -20.5% | |
| – | -13.3% | -16.9% | -17.0% | -23.2% | -33.1% | -27.3% | -19.2% | -16.1% | +231.0% | -22.6% | -20.8% | |
| – | -17.9% | -14.1% | -5.1% | -6.7% | -29.7% | -45.5% | -24.7% | +5.0% | +231.9% | -52.6% | -1.6% | |
| – | -14.8% | -17.2% | -24.8% | -25.0% | -25.5% | -28.5% | -18.7% | -15.4% | +250.2% | -23.4% | -24.5% | |
| – | – | +0.0% | +0.0% | +0.0% | – | – | – | – | – | – | – | |
| – | +0.4% | -11.1% | +4.5% | +2.7% | -51.4% | -55.6% | -42.4% | -8.8% | +1,882.2% | -65.4% | +4.5% | |
| – | +0.8% | -11.2% | +5.1% | +3.2% | -52.7% | -58.2% | -45.7% | -6.5% | +1,604.4% | -86.0% | +17.3% | |
| – | +2.8% | +3.3% | +2.9% | +2.8% | +3.0% | +2.9% | +3.1% | +3.0% | +2.9% | +2.8% | +2.7% | |
| – | -92.5% | +427.9% | -30.2% | -18.3% | -17.8% | +171.8% | -80.3% | +55.6% | +1,624.4% | -61.5% | +37.2% | |
| – | -15.9% | -18.0% | -21.9% | -30.9% | -22.1% | -16.8% | -14.3% | -16.3% | +3.7% | +77.4% | -31.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.6% | +0.2% | +0.4% | -0.1% | +1.5% | +0.1% | +0.9% | +8.4% | +0.0% | +0.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.